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Novel 1,2,3-triazole indolinone derivatives have been synthesized. All the titled 
compounds were characterized by 1H NMR, 13C NMR, MS and IR spectral data. The 
in vitro AChE and BChE inhibitory activity of all the compounds were evaluated. 
 
Introduction:  
Alzheimer disease is the most frequent cause of dementia, which is very common in 
elder population with high morbidity. Treatment of this disease is one of the most 
promising targets in medicinal chemistry researches. Design and synthesis of novel 
1,2,3 diazole indolinone derivatives as cholinesterase inhibitor (ChEI), are 
investigated in this study. Indolinone derivatives with 1,2,3-triazole moiety have 
been recently reported as potential AChE and BuChE inhibitors. There is also, a 
growing interest in evaluating the biological activity of these compounds and their 
derivatives to investigate their role in the prevention of neurodegenerative diseases. 
 
Methods and Results:  
The target compounds were prepared via the 1-methyl-3-((prop-2-yn-1-
yloxy)imino)indolin-2-one as an intermediate in click reaction with substituted 
benzyl halides in water and DMF as solvent in room temperature. All the 
synthesized compounds were characterized by 1H NMR, 13C NMR, MS and IR 




In conclusion, various novel 1,2,3-triazole indolinone derivatives were designed, 
synthesized, and evaluated against AChE and BChE. All these results clearly 
confirmed the efficacy of the corresponding compounds for further drug discovery 
developments. 
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